Angiodynamics (ANGO) Raw Materials (2012 - 2014)

Angiodynamics has reported Raw Materials for 3 years, with the latest figure at $23.3 million in Q1 2014.

• For the quarter ending Q1 2014, Raw Materials changed N/A year-over-year to $23.3 million; the trailing twelve-month figure through Feb 2014 stood at $23.3 million (changed N/A YoY), and the FY2013 full-year result was $18.4 million, down 3.28% from the prior year.
• Raw Materials for Q1 2014 stood at $23.3 million, down from $24.3 million in the prior quarter.
• The five-year high for Raw Materials was $24.3 million in Q4 2013, with the low at $18.4 million in Q2 2013.
• Historically, Raw Materials has averaged $21.2 million across 3 years, with a median of $21.0 million in 2012.
• The largest YoY upside for Raw Materials was 7.67% in 2013 against a maximum downside of 3.28% in 2013.
• Angiodynamics' Raw Materials stood at $20.2 million in 2012, then advanced by 20.17% to $24.3 million in 2013, then declined by 3.99% to $23.3 million in 2014.
• The last three Raw Materials figures came in at $23.3 million (Q1 2014), $24.3 million (Q4 2013), and $21.8 million (Q3 2013), per Business Quant data.